750 related items for PubMed ID: 33912155
1. Increased Pentraxin 3 Levels Correlate With IVIG Responsiveness and Coronary Artery Aneurysm Formation in Kawasaki Disease.
Kitoh T, Ohara T, Muto T, Okumura A, Baba R, Koizumi Y, Yamagishi Y, Mikamo H, Daigo K, Hamakubo T.
Front Immunol; 2021; 12():624802. PubMed ID: 33912155
[Abstract] [Full Text] [Related]
2. A Comprehensive Assessment of the Value of Laboratory Indices in Diagnosing Kawasaki Disease.
Ye Q, Shao WX, Shang SQ, Zhang T, Hu J, Zhang CC.
Arthritis Rheumatol; 2015 Jul; 67(7):1943-50. PubMed ID: 25778686
[Abstract] [Full Text] [Related]
3. [Prediction of the risk of coronary arterial lesions in Kawasaki disease by N-terminal pro-brain natriuretic peptide].
Huiling L, Yaping L, Xiufen H.
Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):300-3. PubMed ID: 26182507
[Abstract] [Full Text] [Related]
4. N-terminal pro-brain natriuretic peptide and risk of coronary artery lesions and resistance to intravenous immunoglobulin in Kawasaki disease.
Yoshimura K, Kimata T, Mine K, Uchiyama T, Tsuji S, Kaneko K.
J Pediatr; 2013 Jun; 162(6):1205-9. PubMed ID: 23290510
[Abstract] [Full Text] [Related]
5. Pro-brain natriuretic peptide (ProBNP) levels in North Indian children with Kawasaki disease.
Reddy M, Singh S, Rawat A, Sharma A, Suri D, Rohit MK.
Rheumatol Int; 2016 Apr; 36(4):551-9. PubMed ID: 26849890
[Abstract] [Full Text] [Related]
6. The role of age-specific N-terminal pro-brain natriuretic peptide cutoff values in predicting intravenous immunoglobulin resistance in Kawasaki disease: a prospective cohort study.
Shao S, Luo C, Zhou K, Hua Y, Wu M, Liu L, Liu X, Wang C.
Pediatr Rheumatol Online J; 2019 Sep 18; 17(1):65. PubMed ID: 31533770
[Abstract] [Full Text] [Related]
7. Interleukin-6 is prone to be a candidate biomarker for predicting incomplete and IVIG nonresponsive Kawasaki disease rather than coronary artery aneurysm.
Wu Y, Liu FF, Xu Y, Wang JJ, Samadli S, Wu YF, Liu HH, Chen WX, Luo HH, Zhang DD, Wei W, Hu P.
Clin Exp Med; 2019 May 18; 19(2):173-181. PubMed ID: 30617865
[Abstract] [Full Text] [Related]
8. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
Yılmazer MM, Özdemir R, Meşe T, Küçük M, Öner T, Devrim İ, Bayram N, Güven B, Tavlı V.
Turk J Pediatr; 2019 May 18; 61(5):648-656. PubMed ID: 32104995
[Abstract] [Full Text] [Related]
9. Prediction of the risk of coronary arterial lesions in Kawasaki disease by brain natriuretic peptide.
Kaneko K, Yoshimura K, Ohashi A, Kimata T, Shimo T, Tsuji S.
Pediatr Cardiol; 2011 Dec 18; 32(8):1106-9. PubMed ID: 21487793
[Abstract] [Full Text] [Related]
10. Natriuretic peptide as an adjunctive diagnostic test in the acute phase of Kawasaki disease.
Dahdah N, Siles A, Fournier A, Cousineau J, Delvin E, Saint-Cyr C, Spiegelblatt L, Bonny Y, Vartian M, Montigny M.
Pediatr Cardiol; 2009 Aug 18; 30(6):810-7. PubMed ID: 19365652
[Abstract] [Full Text] [Related]
11. N-terminal pro-brain natriuretic peptide (NT proBNP) as a predictive indicator of initial intravenous immunoglobulin treatment failure in children with Kawasaki disease: a retrospective study.
Kim SY, Han MY, Cha SH, Jeon YB.
Pediatr Cardiol; 2013 Aug 18; 34(8):1837-43. PubMed ID: 23744100
[Abstract] [Full Text] [Related]
12. [Biomarker].
Ogawa S.
Nihon Rinsho; 2014 Sep 18; 72(9):1578-84. PubMed ID: 25518405
[Abstract] [Full Text] [Related]
13. A comparison of serum IL6 and CRP levels with respect to coronary changes and treatment response in Kawasaki disease patients: a prospective study.
Nandi A, Pal P, Basu S.
Rheumatol Int; 2019 Oct 18; 39(10):1797-1801. PubMed ID: 31302740
[Abstract] [Full Text] [Related]
14. [Change in plasma N-terminal pro-brain natriuretic peptide in children with Kawasaki disease and its value in clinical practice].
Zhang QY, Du JB, Chen YH, Li WZ.
Zhonghua Er Ke Za Zhi; 2006 Dec 18; 44(12):886-90. PubMed ID: 17254452
[Abstract] [Full Text] [Related]
15. Risk of coronary artery lesions in young infants with Kawasaki disease: need for a new diagnostic method.
Satoh K, Wakejima Y, Gau M, Kiguchi T, Matsuda N, Takasawa R, Takasawa K, Nishioka M, Shimohira M.
Int J Rheum Dis; 2018 Mar 18; 21(3):746-754. PubMed ID: 29105337
[Abstract] [Full Text] [Related]
16. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
Xie T, Wang Y, Fu S, Wang W, Xie C, Zhang Y, Gong F.
Pediatr Rheumatol Online J; 2017 Mar 21; 15(1):17. PubMed ID: 28320400
[Abstract] [Full Text] [Related]
17. Elevated Levels of Platelet Activating Factor and Its Acetylhydrolase Indicate High Risk of Kawasaki Disease.
Yi L, Zhang J, Zhong J, Zheng Y.
J Interferon Cytokine Res; 2020 Mar 21; 40(3):159-167. PubMed ID: 31841639
[Abstract] [Full Text] [Related]
18. Predictive value of monocyte to HDL-C ratio for coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease.
Wang JR, Zhao HZ, Chang LJ, Xu X, Gao Y, Li M, Kong QY, Wang MM, Zhao CF.
Eur J Pediatr; 2023 Oct 21; 182(10):4399-4406. PubMed ID: 37480545
[Abstract] [Full Text] [Related]
19. N-terminal pro-brain natriuretic peptide in acute Kawasaki disease correlates with coronary artery involvement.
Adjagba PM, Desjardins L, Fournier A, Spigelblatt L, Montigny M, Dahdah N.
Cardiol Young; 2015 Oct 21; 25(7):1311-8. PubMed ID: 25544036
[Abstract] [Full Text] [Related]
20. Evaluation of laboratory predictors for intravenous immunoglobulin resistance and coronary artery aneurysm in Kawasaki Disease before and after therapy.
Liu J, Ye B, Su D, Qin S, Zhao W, Pang Y.
Clin Rheumatol; 2023 Jan 21; 42(1):167-177. PubMed ID: 36129563
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
